Lower Limb Spasticity Clinical Trial
Official title:
A Prospective, Observational Study to Assess Pain Relief After 4 Botulinum Toxin Type A (BoNT-A) Injection Cycles in Patients With Post-stroke Lower Limb Spasticity
The objective of this study is to demonstrate the effect of intramuscular BoNT-A injections
in relieving pain, in a broad population of patients who suffer pain as the primary problem
associated with spasticity. Thus, this study will help to expand the information that is
available regarding the impact of BoNT-A treatment in routine clinical practice conditions.
Treatment goals can vary greatly from one patient to another and there is no unique, single
outcome that reflects the treatment benefits in all the cases. Therefore, this study with
special focus on the achievement of therapeutic goals, will allow the identification of each
patient's specific goals regarding the improvement of the functional outcomes, the quality of
life and patient well-being.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03017729 -
Effectiveness and Safety of Dysport® (abobotulinumtoxinA) in Paediatric Lower Limb Spasticity
|